LFCR

시간 외 거래: 6.29 -0.09 -1.41%

Lifecore Biomedical Inc (LFCR)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1052)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

최신 SEC 제출 서류

LFCR's Discussions on Twitter

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LFCR Lifecore Biomedical Inc	6.38	241.84M	147.12M	-33.88M	2.63M	-0.4805
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-17	업그레이드	Barrington Research	Mkt Perform → Outperform
2025-09-04	개시	KeyBanc Capital Markets	Sector Weight
2025-05-21	개시	William Blair	Outperform
2024-09-05	개시	Craig Hallum	Buy
2024-08-28	다운그레이드	Barrington Research	Outperform → Mkt Perform
2023-03-20	다운그레이드	Stephens	Overweight → Equal-Weight

Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스

Lifecore Biomedical Inc (LFCR) 재무 분석

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스

Press Releases about Mistras Group Inc Common Stock (NYSE:MG) - FinancialContent

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Na - StreetInsider

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD) - Procurement Magazine

Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ) - Supply Chain Digital

Votes against certain rival proposals are part of Wynnefield's merger pledge at Lifecore Biomedical (LFCR). - Stock Titan

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR) - Morningstar

Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News - Investorideas.com

Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com Nigeria

Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com India

Form 13D/A LIFECORE BIOMEDICAL For: 28 September By Investing.com - Investing.com Canada

A $6.28-a-share merger gets a voting pledge from Legion Partners at Lifecore Biomedical (LFCR). - Stock Titan

LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

Form 8K Lifecore Biomedical Inc For: 28 September By Investing.com - Investing.com Nigeria

Form 8K Lifecore Biomedical Inc For: 28 September By Investing.com - Investing.com UK

Lifecore Biomedical to be acquired by Webster Equity Partners - TradingView

A 49.5% premium is built into Lifecore Biomedical’s (LFCR) proposed sale. The cash price is only part of the deal. - Stock Titan

Lifecore Biomedical to be Acquired by Webster Equity Partners - GlobeNewswire

Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business (NASDAQ:LFCR) - Seeking Alpha

Lifecore plans customer meetings in Milan this October - Stock Titan

Lifecore Biomedical to Participate at CPHI Global Conference - Yahoo Finance

Lifecore Strikes Tech Transfer Deal for Commercial Manufacturing of Major Pharma Company Injectable - Contract Pharma

Lifecore Biomedical Signs New Commercial Transfer Agreement for Marketed Injectable Product - Quiver Quantitative

A marketed injectable drug is expected to bring Lifecore revenue in 2028. - Stock Titan

LFCR Q2 2026 Earnings: Narrower Loss of -$0.19 Beats Estimates, Shares Dip 1.35%Revenue Guidance Update - vinanet.vn

Lifecore (LFCR) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Session Move: Shares Rise 0.22% at the CloseEarnings Season Preview - vinanet.vn

Lifecore (LFCR) Earnings Reading: EPS Prints Above Forecast at the Close; After Results: Shares Move 2.42% Down on the DayGuidance Downgrade Alert - vinanet.vn

LFCR | Lifecore Biomedical, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative

Lifecore Biomedical Earnings Call Balances Growth and Strain - TipRanks

Lifecore (LFCR) Quarterly Scorecard: EPS Beats Its Estimate; The Stock Records a 1.83% Increase on the DayROA Comparison - vinanet.vn

Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity - Yahoo Finance

Avoiding Lag: Real-Time Signals in (LFCR) Movement - Stock Traders Daily

Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - AOL.com

LFCR Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 16.59% EPS SurpriseAnalyst Coverage Count - vinanet.vn

Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerSell Signal Alerts - vinanet.vn

LFCR Q2 2026 Earnings: Narrower-than-Expected Loss Offers Modest EncouragementGuidance vs Actual - vinanet.vn

Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerCash Secured Put - dars.gov.et

Judge approves $3.75 million Lifecore investor settlement - Minnesota Lawyer

Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - The Globe and Mail

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - marketscreener.com

Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Discipline and Rules-Based Execution in LFCR Response - Stock Traders Daily

Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com Canada

Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com

Transcript : Lifecore Biomedical, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com

Lifecore Biomedical, Inc. Reaffirms Earnings Guidance for the Calendar Year 2026 - marketscreener.com

LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook - TradingView

Lifecore Biomedical, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Lifecore Biomedical Inc (LFCR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

LFCR과 유사한 종목